Identification of cis-acting repressor activity within human immunodeficiency virus type 1 protease sequences

Virology

Volumn 234, Issue 2, 1997, Pages 253-260

  Huffman, Kim M ^a   Arrigo, Salvatore J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; VIRUS RNA;

ANIMAL CELL; ARTICLE; GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REPRESSOR GENE; RNA SEQUENCE;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030854491     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8655     Document Type: Article

References (45)

1. Arrigo S. J., Chen I. S. Y. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu-2 RNAs. Genes Dev. 5:1991;808-819.
2. Arrigo S. J., Huffman K. Potent inhibition of human immunodeficiency virus type 1 (HIV-1) replication by inducible expression of HIV-1 PR multimers. J. Virol. 69:1995;5988-5994.
3. Arrigo S. J., Haines J. K., Huffman K. M. Intrinsic activity of human immunodeficiency virus type 1 protease heterologous fusion proteins in mammalian cells. DNA Cell Biol. 14:1995;15-23.
4. Barksdale S. K., Baker C. C. The human immunodeficiency virus type 1 Rev protein and the Rev-responsive element counteract the effect of an inhibitory 5′ splice site in a 3′ untranslated region. Mol. Cell. Biol. 15:1995;2962-2971.
5. Brighty D. W., Rosenberg M. A cis-acting repressive sequence that overlaps the Rev-responsive element of human immunodeficiency virus type 1 regulates nuclear retention of env mRNAs independently of known splice signals. Proc. Natl. Acad. Sci. USA. 91:1994;8314-8318.
6. Campbell L. H., Borg K. T., Arrigo S. J. Differential effects of intronic and exonic locations of the human immunodeficiency virus type 1 Rev-responsive element. Virology. 219:1996;423-431.
7. Chang D. D., Sharp P. A. Regulation by HIV Rev depends upon recognition of splice sites. Cell. 59:1989;789-795.
8. Churchill M. J., Moore J. L., Rosenberg M., Brighty D. W. The rev-responsive element negatively regulates human immunodeficiency virus type 1 env mRNA expression in primate cells. J. Virol. 70:1996;5786-5790.
9. Cochrane A. W., Jones K. S., Beidas S., Dillon P. J., Skalka A. M., Rosen C. A. Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J. Virol. 65:1991;5305-5313.
10. Dayton A. I. The Rev axis of HIV-1 and its associated host cofactors: a viral window onto the workings of eukaryotic posttranscriptional RNA processing. J. Biomed. Sci. 3:1996;69-77.
11. Dyhr M. H., Kjems J. Inefficient spliceosome assembly and abnormal branch site selection in splicing of an HIV-1 transcript in vitro. J. Biol. Chem. 270:1995;24060-24066.
12. Favaro J. P., Arrigo S. J. Characterization of Rev function using subgenomic and genomic constructs in T and COS cells. Virology. 228:1997;29-38.
13. Feinberg M. B., Jarrett R. F., Aldovini A., Gallo R. C., Wong S. F. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell. 46:1986;807-817.
14. Felber B. K., Hadzopoulou C. M., Cladaras C., Copeland T., Pavlakis G. N. rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA. 86:1989;1495-1499.
15. Fischer U., Huber J., Boelens W. C., Mattaj I. W., Luhrmann R. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell. 82:1995;475-483.
16. Fischer U., Meyer S., Teufel M., Heckel C., Luhrmann R., Rautmann G. Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA. EMBO J. 13:1994;4105-4112.
17. Gatlin J., Campbell L. H., Schmidt M. G., Arrigo S. J. Direct-rapid (DR) mutagenesis of large plasmids using PCR. Biotechniques. 19:1995;559-564.
18. Hadzopoulou C. M., Felber B. K., Cladaras C., Athanassopoulos A., Tse A., Pavlakis G. N. The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region. J. Virol. 63:1989;1265-1274.
19. Hammarskjöld M. L., Li H., Rekosh D., Prasad S. Human immunodeficiency virus env expression becomes Rev-independent if the env region is not defined as an intron. J. Virol. 68:1994;951-958.
20. Kaplan A. H., Swanstrom R. The HIV-1 gag precursor is processed via two pathways: Implications for cytotoxicity. Biomed. Biochim. Acta. 50:1991a;647-653.
21. Kaplan A. H., Swanstrom R. Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments. Proc. Natl. Acad. Sci. USA. 88:1991b;4528-4532.
22. Keller R., Montagnier L., Cordonnier A. Characterization of a nuclear retention sequence within the 3′ region of the HIV-2 envelope gene. Virology. 192:1993;33-37.
23. Kohl N. E., Emini E. A., Schleif W. A., Davis L. J., Heimbach J. C., Dixon R. A., Scolnick E. M., Sigal I. S. Active human immunodeficiency virus protease is required for viral infectivity. Proc. Natl. Acad. Sci. USA. 85:1988;4686-4690.
24. Kramer R. A., Schaber M. D., Skalka A. M., Ganguly K., Wong-Staal F., Reddy E. P. HTLV-IIIgagpol. Science. 231:1986;1580-1584.
25. Krausslich H. G. Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity. Proc. Natl. Acad. Sci. USA. 88:1991;3213-3217.
26. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
27. Luukkonen B. G., Fenyo E. M., Schwartz S. Overexpression of human immunodeficiency virus type 1 protease increases intracellular cleavage of Gag and reduces virus infectivity. Virology. 206:1995;854-865.
28. Maldarelli F., Martin M. A., Strebel K. Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type-1 RNA - Novel level of gene regulation. J. Virol. 65:1991;5732-5743.
29. Malim M. H., Cullen B. R. Rev and the fate of pre-mRNA in the nucleus: Implications for the regulation of RNA processing in eukaryotes. Mol. Cell. Biol. 13:1993;6180-6189.
30. Mikaelian I., Krieg M., Gait M. J., Karn J. Interactions of INS (CRS) elements and the splicing machinery regulate the production of Rev-responsive RNAs. J. Mol. Biol. 257:1996;246-264.
31. Morrow C. D., Park J., Wakefield J. K. Viral gene products and replication of the human immunodeficiency type 1 virus. Am. J. Physiol. 266:1994;C1135-C1156.
32. Nasioulas G., Zolotukhin A. S., Tabernero C., Solomin L., Cunningham C. P., Pavlakis G. N., Felber B. K. Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA. J. Virol. 68:1994;2986-2993.
33. Olsen H. S., Cochrane A. W., Rosen C. Interaction of cellular factors with intragenic cis-acting repressive sequences within the HIV genome. Virology. 191:1992;709-715.
34. Prince A. M. Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV. Proc. Natl. Acad. Sci. USA. 85:1988;6944-6948.
35. Prince A. M., Reesink H., Pascual D., Horowitz B., Hewlett I., Murthy K. K., Cobb K. E., Eichberg J. W. Prevention of HIV infection by passive immunization with HIV immunoglobulin. AIDS Res. Hum. Retroviruses. 7:1991;971-973.
36. Reddy T. R., Kraus G., Suhasini M., Leavitt M. C., Wong S. F. Identification and mapping of inhibitory sequences in the human immunodeficiency virus type 2 vif gene. J. Virol. 69:1995;5167-5170.
37. Rekosh D., Nygren A., Flodby P., Hammarskjöld M. L., Wigzell H. Coexpression of human immunodeficiency virus envelope proteins and tat from a single simian virus 40 late replacement vector. Proc. Natl. Acad. Sci. USA. 85:1988;334-338.
38. Rosen C. A., Terwilliger E., Dayton A., Sodroski J. G., Haseltine W. A. Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 85:1988;2071-2075.
39. Schwartz S., Campbell M., Nasioulas G., Harrison J., Felber B. K., Pavlakis G. N. Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J. Virol. 66:1992a;7176-7182.
40. Schwartz S., Felber B. K., Pavlakis G. N. Distinct RNA sequences in the gag region of human immunodeficiency virus type-1 decrease RNA stability and inhibit expression in the absence of Rev protein. J. Virol. 66:1992b;150-159.
41. Smith A. J., Cho M. I., Hammarskjöld M. L., Rekosh D. Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles. J. Virol. 64:1990;2743-2750.
42. Sodroski J., Goh W. C., Rosen C., Dayton A., Terwilliger E., Haseltine W. A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature. 321:1986;412-417.
43. Southern P. J., Berg P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:1982;327-341.
44. Tan W., Schalling M., Zhao C., Luukkonen M., Nilsson M., Fenyo E. M., Pavlakis G. N., Schwartz S. Inhibitory activity of the equine infectious anemia virus major 5′ splice site in the absence of Rev. J. Virol. 70:1996;3645-3658.
45. Tan W., Schwartz S. The Rev protein of human immunodeficiency virus type 1 counteracts the effect of an AU-rich negative element in the human papillomavirus type 1 late 3′ untranslated region. J. Virol. 69:1995;2932-2945.